Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer

Clinical trial NCT00082810 · COMPLETED

Trial details

NCT number: NCT00082810
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Estrogen Receptor-positive Breast Cancer Recurrent Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer

Start date: 2004-03-01
Primary completion: 2008-07-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.